Didier Blondel
EVP, CFO & Board SecretaryMr. Didier Blondel serves as Executive Vice President and Board Secretary of ABIVAX Société Anonyme since January 2017 and served as its Vice President and served as its Administrative and Financial Director. Mr. Blondel serves as the Chief Financial Officer at ABIVAX Société Anonyme since January 2, 2017. He joined ABIVAX Société Anonyme in December 2016. Mr. Blondel served as the Chief Financial Officer at Sanofi Pasteur MSD since 2012. During the previous several years period, he held a wide scope of senior finance positions at Sanofi, in Commercial Operations and then R&D, where he became Global R&D Chief Financial Officer. Mr. Blondel started his career as an Auditor at Price Waterhouse Coopers. He has a Professional Certificate in Finance and Accounting (DESCF). He graduated from the Commercial Institute of Nancy (ICN), a leading French Business School. He also holds a Master in Finance and Accounting degree from University of Nancy.
Positions
- Company NameABIVAX Société AnonymeStock CodeABVXPositionEVP, CFO & Board SecretaryColleagues
- MMMarc M. P. de GaridelCEO & Director
- SLSylvie L. GregoireIndependent Chair of the Board
- TPTimothy P. KellyChief Technical Officer
- PMPatrick MalloySenior VP & Head of Investor Relations
- IHIda HatoumChief People & Compliance Officer
- IMIan McGowanChairman of Scientific Advisory Board
- JHJune H. LeeIndependent Director
- TATroy A. IgnelziIndependent Director
